The Situation and Countermeasure of Current Children's Medicine

Abstract

Abstract: Through analysing the current situation of pediatric drugs and pediatric characteristics to identify the current problems of pediatric drugs and adverse consequences caused by incorrect drug use, as well as to clarify the necessity of clinical research for pediatric drugs, the development of drugs for children and standardization of drug use. Combined with national laws and regulations on children's medication abroad, we provide a reference for China to formulate relevant policies and measures.

Key words: pediatric drugs, current situation, clinical research, countermeasure

CLC Number:

R951

WANG Chun-ting, LI Yu-ji, XIA Dong-sheng ,TIAN Chun-hua. The Situation and Countermeasure of Current Children's Medicine [J]. Chinese Journal of Pharmacovigilance, 2013, 10(8): 492-496.

References

[1] 梁小丽.浅谈儿童用药安全[J].中国实用医药,2011,6（11）：182-183.
[2] 陈倩,杜光,张带荣.儿童用药及其临床研究的现状与进展[J].医药导报[J]. 医药导报,2011,30（5）：593-596.
[3] 中华人民共和国国家统计局.2010 年第六次全国人口普查主要数据公报（第1 号）[DB/d].http://www.stats.gov.cn/tjgb/rkpcgb/qgrkpcgb/t20110428_402722232.htm.
[4] 余明莲,杨悦.我国儿童用药可获得性的调查分析[J].解放军药学学报,2011,27（4)：368-372.
[5] 郭晓昕,颜敏,李少丽.国内外儿童用药现状与思考[J].中国药房,2000,11（5）：196-199.
[6] 马家猛,盂刘虹.儿童用药现状分析[J].中国中医药现代远程教育,2011,9(8)：163-165.
[7] 江君微.756 份药品说明书中儿童用药项的调查分析[J].中国药业,2012,2l（22）：6-7.
[8] 王翔岩,李英涛,张翠莲.192 种中成药说明书中特殊人群用药信息的调查分析[J].中国药事,2011,25（7）：667-669.
[9] SHARON C,Unlicensed and Off-lable drug use issues and recommendations[J].Pediatric Drugs,2002,4(6);353-359.
[10] C.ASoH ASHP statement on the use of medications for unlabeleduses[J].Am J Hosp Pharm,1992,49(8):2006-2008.
[11] Barr J,Brenner-ZadaG,HeimanE,etal.Unlicensed and off-lable medication use in a neonatal intensive care unit:a prospective study[J].Am J Perinatol,2002,19(2):67-72.
[12] Bavdekar S B, Sadawarte P A, Gogtay N J, et al. Off-label drug use in a Pediatric Intensive Care Unit[J].Indian J Pediatr, 2009, 76(11): 1113-1118.
[13] 张伶俐,李幼平,胡蝶,等. 四川大学华西第二医院2010 年儿科住院患儿超说明书用药情况调查[J].中国循证医学杂志,2012,12（2）：161-167.
[14] 张伶俐,李幼平,黄亮,等.四川大学华西第二医院2010 年儿科门诊患儿超说明书用药情况调查中国循证医学杂志,2012,12（3）：267-273.
[15] 张伶俐,李幼平,梁毅,等.全球门诊儿童超说明书用药现状的系统评价[J].中国循证医学杂志,2012,12（3）：305-313.
[16] ZHANG B,LI D K,YANG X. The use of medications for unabled uses[J].Chin J Rheumatol(中国风湿病学杂志),2004,8(8)：451-453.
[17] 韩和芹.浅谈儿童用药存在的问题及解决对策[J].《求医问药)-下半月刊,2012,10（1）：458.
[18] 张颖.我院儿科用药现状分析[J].实用药物与I 临床2011,14(5):406-407.
[19] 宋德辉.我国家庭用药现状及对策展望[J].中国医药指南,2011,9（36）：224-225.
[20] FDA.Best Pharmaceuticals for Children Act[EB/OL].Legislation/Federal Food Drug and Cosmetic ActFDCAct/Significant Amendments to the FDCAct/ucm148011.htm.
[21] FDA. Pediatric Research Equity Act[EB/OL].http://www.fda.gov/AboutFDA/What We Do/History/Milestones/default.htm.
[22] CFDA.国家食品药品监管局召开儿童用药安全座谈会[EB/OL].http://www.sda.gov.cn/WS01/CL0050/72113.html.
[23] CFDA. 国家食品药品监督管理局关于深化药品审评审批改革进一步鼓励药物创新的意见[EB/OL].http://www.sda.gov.cn/WS01/CL0844/78576.html.
[24] 田春华,沈璐.儿科临床研究与儿童用药安全[J].中国药物警戒,2009,6（9）：518-521.